Issues related to Medicare & Medicaid disbursement. Site-neutral payment policy.
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement.
Issues related to congressional directed funding.
Duration: January 1, 2017
to
present
General Issues: Medicare/Medicaid , Health Issues , Budget/Appropriations , Insurance , Medical/Disease Research/Clinical Labs , Pharmacy
Spending: about $2,310,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: Centers For Medicare and Medicaid Services (CMS), U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Kristin Welsh Senate Finance Committee, Deputy Health Policy Director, Senator Hatch;
Senate HELP Committee, Health Policy Advisor, Senator Jeffords;
Senate Labor and Human Resources Committee, Health Policy Research Asst, Senator Kassebaum.
Kate Rose Senior Health Policy Advisor, Representative Allyson Schwartz; Health LA, Senator John D. Rockefeller.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $110,000. The report was filed on April 9.
Original Filing: 301547452.xml
Lobbying Issues
Issues related to Medicare & Medicaid disbursement. Site-neutral payment policy.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to congressional directed funding.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $110,000. The report was filed on Jan. 15.
Original Filing: 301524516.xml
Lobbying Issues
Issues related to Medicare & Medicaid disbursement. Site-neutral payment policy.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $110,000. The report was filed on Oct. 4, 2023.
Original Filing: 301497721.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023. Site-neutral payment policy.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $110,000. The report was filed on July 12, 2023.
Original Filing: 301474792.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023. Site-neutral payment policy.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $110,000. The report was filed on April 13, 2023.
Original Filing: 301451518.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. PDUFA reauthorization and VALID Act. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $110,000. The report was filed on Jan. 13, 2023.
Original Filing: 301427400.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. PDUFA reauthorization and VALID Act. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $110,000. The report was filed on Oct. 10, 2022.
Original Filing: 301402310.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. PDUFA reauthorization and VALID Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Hospital infrastructure funding. School based health center funding.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $110,000. The report was filed on July 15, 2022.
Original Filing: 301380715.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs. PDUFA reauthorization and VALID Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Hospital infrastructure funding. School based health center funding.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $110,000. The report was filed on April 14, 2022.
Original Filing: 301356302.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Hospital infrastructure funding. School based health center funding.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2021
In Q4, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $90,000. The report was filed on Jan. 13, 2022.
Original Filing: 301322282.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Hospital infrastructure funding. School based health center funding.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $90,000. The report was filed on Oct. 15, 2021.
Original Filing: 301300056.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to school-based health center funding. Issues related to Medicare & Medicaid disbursement. Issues related to The Provider Relief Fund and other Covid costs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Hospital infrastructure funding. School based health center funding.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $90,000. The report was filed on July 13, 2021.
Original Filing: 301275780.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to private insurance.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Hospital infrastructure funding.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $90,000. The report was filed on April 12, 2021.
Original Filing: 301251901.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid disbursement. PL 117-2, The American Rescue Plan Act of 2021.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding. PL 117-2, The American Rescue Plan Act of 2021.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to private insurance.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on Jan. 20, 2021.
Original Filing: 301242150.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement. Issues related to H.R.748/S.3548, CARES Act. H.R. 133, the Consolidated Appropriations Act of 2021 and issues related to COVID relief.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding. Issues related to H.R.748/S.3548, CARES Act. H.R. 133, the Consolidated Appropriations Act of 2021; surprise billing.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on Oct. 16, 2020.
Original Filing: 301211960.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement. Issues related to H.R.748/S.3548, CARES Act.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding. Issues related to H.R.748/S.3548, CARES Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on July 15, 2020.
Original Filing: 301188253.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement. Issues related to H.R.748/S.3548, CARES Act.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding. Issues related to H.R.748/S.3548, CARES Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on April 20, 2020.
Original Filing: 301177362.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement. Issues related to H.R.748/S.3548, CARES Act.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding. Issues related to H.R.748/S.3548, CARES Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on Jan. 16, 2020.
Original Filing: 301107364.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on Oct. 16, 2019.
Original Filing: 301066330.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on July 19, 2019.
Original Filing: 301051751.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on April 15, 2019.
Original Filing: 301025105.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on Jan. 10, 2019.
Original Filing: 301003588.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on Oct. 22, 2018.
Original Filing: 300994176.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on July 20, 2018.
Original Filing: 300976688.xml
Lobbying Issues
Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on April 13, 2018.
Original Filing: 300944475.xml
Lobbying Issues
H.R. 1892, Bipartisan Budget Act of 2018, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Title V Maternal and Child Health Services Block Grants.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1892, Bipartisan Budget Act of 2018, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Medicare and Medicaid reimbursement. Issues related to 340B drug pricing.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding.
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on Jan. 18, 2018.
Original Filing: 300927100.xml
Lobbying Issues
HR 1628, American Health Care Act of 2017, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Title V Maternal and Child Health Services Block Grants.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 1628, American Health Care Act of 2017, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Medicare and Medicaid reimbursement. Issues related to 340B drug pricing.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on Oct. 19, 2017.
Original Filing: 300910743.xml
Lobbying Issues
HR 1628, American Health Care Act of 2017, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Title V Maternal and Child Health Services Block Grants.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 1628, American Health Care Act of 2017, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Medicare and Medicaid reimbursement. Issues related to 340B drug pricing.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on July 19, 2017.
Original Filing: 300890529.xml
Lobbying Issues
HR 1628, American Health Care Act of 2017, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 1628, American Health Care Act of 2017, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Medicare and Medicaid reimbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to Medicare and Medicaid reform, drug pricing and NIH funding.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Welsh Rose, LLC lobbied for Montefiore Medical Center , earning $60,000. The report was filed on April 10, 2017.
Original Filing: 300863450.xml
Lobbying Issues
HR 1628, American Health Care Act of 2017, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 1628, American Health Care Act of 2017, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Medicare and Medicaid reimbursement.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2017
Welsh Rose, LLC filed a lobbying registration on Feb. 14, 2017 to represent Montefiore Medical Center, effective Jan. 1, 2017.
Original Filing: 300860401.xml
Issue(s) they said they’d lobby about: Advocate on behalf of Montefiore with respect to issues that affect public health care programs, medical research, the Affordable Care Act and other issues, as needed, that affect either the health system and/or the medical school. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...